A study performed by Quek et al. in patients with relapsed refractory AML showed increased variant allele frequency in the colony-stimulating factor 3 receptor (CSF3R) gene, FLT3, and Cbl proto-oncogene (CBL), which is a negative regulator of cytokine signaling. This evidence concerns the gene FLT3 and acute myeloid leukemia.